Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)

<p>Abstract</p> <p>Background</p> <p>Hypertension and type 2 diabetes are common co-morbidities. Preliminary studies suggest that thiazolidinediones reduce blood pressure (BP). We therefore used ambulatory BP to quantify BP lowering at 6–12 months with rosiglitazone used in combination with metformi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zambanini Andrew, Pocock Stuart J, Beck-Nielsen Henning, Hanefeld Markolf, Curtis Paula, Komajda Michel, Jones Nigel P, Gomis Ramon, Home Philip D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2008-04-01
coleção:	Cardiovascular Diabetology
Acesso em linha:	http://www.cardiab.com/content/7/1/10
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!